Effects on gastric circulation of treatment for portal hypertension in cirrhosis
- PMID: 9635622
- DOI: 10.1023/a:1018872227652
Effects on gastric circulation of treatment for portal hypertension in cirrhosis
Abstract
We evaluated the gastric circulatory effects of the type of treatment administered for portal hypertension. Of 14 patients with cirrhosis, seven received a transjugular intrahepatic portosystemic shunt (TIPS; group T) and seven received percutaneous transhepatic portographic embolization (PTPE; group P). Patients were evaluated over the course of one year. After treatment, portal venous pressure was significantly reduced from 39 +/- 6 cm H2O to 32 +/- 5 (P < 0.001) in group T and was significantly elevated from 29 +/- 10 to 33 +/- 8 (P < 0.05) in group P. The portal flow velocity (Vmean) was significantly higher in group T vs group P (P < 0.0001). The congestion index was significantly lower in group T than in group P (P < 0.0001). The gastric mucosal blood flow was increased in group T but was unchanged in group P. Esophageal varices showed some improvement in both groups, but the portal hypertensive gastropathy was improved only in group T. These findings help to explain the differing effects on the gastric circulation related to the type of treatment used for portal hypertension.
Similar articles
-
Effect of transjugular intrahepatic portosystemic shunt formation on portal hypertensive gastropathy and gastric circulation.Am J Gastroenterol. 2001 Apr;96(4):1155-9. doi: 10.1111/j.1572-0241.2001.03694.x. Am J Gastroenterol. 2001. PMID: 11316163
-
Portal and gastric mucosal hemodynamics in cirrhotic patients with portal-hypertensive gastropathy.Hepatology. 1994 Dec;20(6):1432-6. doi: 10.1002/hep.1840200609. Hepatology. 1994. PMID: 7982641
-
Transjugular intrahepatic portosystemic shunts and portal hypertension-related complications.World J Gastroenterol. 2014 Dec 7;20(45):16996-7010. doi: 10.3748/wjg.v20.i45.16996. World J Gastroenterol. 2014. PMID: 25493012 Free PMC article. Review.
-
Combined transjugular intrahepatic portosystemic shunt and other interventions for hepatocellular carcinoma with portal hypertension.World J Gastroenterol. 2015 Nov 21;21(43):12439-47. doi: 10.3748/wjg.v21.i43.12439. World J Gastroenterol. 2015. PMID: 26604651 Free PMC article.
-
The role of transjugular intrahepatic portosystemic shunt (TIPS) in the management of portal hypertension.J Clin Gastroenterol. 2007 Nov-Dec;41 Suppl 3:S344-51. doi: 10.1097/MCG.0b013e318157e500. J Clin Gastroenterol. 2007. PMID: 17975487 Review.
Cited by
-
Portal hypertensive gastropathy: A systematic review of the pathophysiology, clinical presentation, natural history and therapy.World J Hepatol. 2016 Feb 8;8(4):231-62. doi: 10.4254/wjh.v8.i4.231. World J Hepatol. 2016. PMID: 26855694 Free PMC article.
-
Portal hypertensive gastropathy and gastric antral vascular ectasia (GAVE) syndrome.Gut. 2001 Dec;49(6):866-72. doi: 10.1136/gut.49.6.866. Gut. 2001. PMID: 11709525 Free PMC article. Review. No abstract available.
References
MeSH terms
LinkOut - more resources
Full Text Sources